Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 4/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.39 |
| ▸ | CTSA | P10619 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19804606 | 0.93 | SLC6A9 (0.40) | FEN1ALOX5APCYP4F2CYP4A11CYP11B1 | |
| SCHEMBL19801616 | 0.91 | FEN1 (0.49) | FEN1ALOX5APFFAR4ALDH1A1KDM4E | |
| SCHEMBL19796787 | 0.88 | RARB (0.49) | FEN1ALOX5APCYP4F2CYP4A11FFAR4 | |
| SCHEMBL19796941 | 0.86 | RARB (0.47) | FEN1ALOX5APCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL19804253 | 0.86 | EGFR (0.47) | CYP11B1CYP11B2ALDH1A1PDE4AEGFR | |
| SCHEMBL19804168 | 0.86 | SLC6A9 (0.40) | FEN1ALOX5APCYP11B1CYP11B2FFAR4 | |
| SCHEMBL19804349 | 0.86 | FEN1 (0.51) | FEN1ALOX5APCYP11B1CYP11B2FFAR4 | |
| SCHEMBL19804344 | 0.85 | ALOX5AP (0.39) | FEN1ALOX5APALDH1A1PGRPTGS1 | |
| SCHEMBL19804161 | 0.84 | SLC6A9 (0.39) | FEN1ALOX5APCYP11B1CYP11B2ALDH1A1 | |
| SCHEMBL19803992 | 0.84 | FFAR4 (0.44) | CYP4F2CYP4A11CYP11B1CYP11B2CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | FEN1 2669/4885ALOX5AP 2507/4885CYP4F2 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.